Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

5-(6-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo(2,1-f)(1,2,4)triazin-4-ylamino)-2,4-difluoro-N-methoxybenzamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
5-(6-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo(2,1-f)(1,2,4)triazin-4-ylamino)-2,4-difluoro-N-methoxybenzamide
Unique ID
C501753
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C501753
Entry Term(s)
DOITDM cpd
Registry Numbers
0
Heading Mapped to
*Oxadiazoles
*Triazines
Frequency
1
Note
an FGFR-1 antagonist; structure in first source
Source
J Med Chem 2005 Jun 16;48(12):3991-4008
Indexing Information
Receptors, Fibroblast Growth Factor
Vascular Endothelial Growth Factor Receptor-2
Date of Entry
2005/07/03
Revision Date
2005/07/03
5-(6-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo(2,1-f)(1,2,4)triazin-4-ylamino)-2,4-difluoro-N-methoxybenzamide Preferred
page delivered in 0.004s